CD8A and non-small cell lung carcinoma: In TS, a high density of CD8+ TILs also indicated a better OS (HR = 0.997; 95% CI, 0.99–1.0; p<0.001), PFS (HR = 0.40; 95% CI, 0.10–0.69; p = 0.008), DFS (HR = 0.54; 95% CI, 0.17–0.92; p = 0.004) and DSS (HR = 0.45; 95% CI, 0.30–0.59; p<0.001) for patients with NSCLC (S5 Fig).